Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

25

Revenue 2017

CSL

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of CSL's 2013 sales performance.

EMA starts rapid review of Shire’s HAE antibody

EMA starts rapid review of Shire’s HAE antibody

Other approved treatments for HAE include CSL Behring’s Berinert and Pharming’s Ruconest.

Pharma deals continue to slide

Pharma deals continue to slide 425 (upfront 80). Calimmune (US). CSL (AU). Company acquisition. Preclinical haematopoietic stem cell therapy for sickle cell disease.

Novo Nordisk's long-acting haemophilia B drug cleared by FDA

Novo Nordisk's long-acting haemophilia B drug cleared by FDA Novo Nordisk's long-acting haemophilia B drug cleared by FDA. US approval sets up marketing battle with Bioverativ and CSL Behring. ... Novo Nordisk has claimed US approval for Rebinyn, its long-acting Factor IX for haemophilia B, setting up a marketing

Deal Watch January 2017

Deal Watch January 2017 625. Momenta. CSL. Licence. M230 immuno-modulator of Fc receptors. 600. ImmuNext.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

blood
‘How is your day?’
The initiative that shows how plasma protein therapies improve lives...
women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....

Infographics